Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M103,526Revenue $M41,414Net Margin (%)17.6Z-Score2.1
Enterprise Value $M128,762EPS $1.7Operating Margin %22.5F-Score6
P/E(ttm))16.2Cash Flow Per Share $0Pre-tax Margin (%)21.0Higher ROA y-yY
Price/Book13.210-y EBITDA Growth Rate %3.1Quick Ratio0.7Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %2.4Current Ratio1.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-22.6ROA % (ttm)10.4Higher Current Ratio y-yN
Dividend Yield %6.1Insider Buy (3m)0ROE % (ttm)68.0Less Shares Outstanding y-yY
Payout Ratio %93.0Shares Outstanding M4,804ROI % (ttm)14.0Gross Margin Increase y-yN

Gurus Latest Trades with GLAXF

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

GLAXF is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

GLAXF: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29303.21view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$1277.75view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$1452.36view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$1277.75view

Press Releases about GLAXF :

    Quarterly/Annual Reports about GLAXF:

      News about GLAXF:

      Articles On GuruFocus.com
      tester Dec 18 2014 
      Weekly 3-Year Low Highlights: RDS.B, GSK, WPZ, CLR Dec 14 2014 
      Pfizer Spreading Its Wings Into A New Domain Of Life Sciences Dec 09 2014 
      The Top 5 European Stocks Held During Q3 Nov 25 2014 
      Jeff Auxier Buys Berkshire Hathaway in Third Quarter Nov 18 2014 
      Irving Kahn Starts New Position In GlaxoSmithKline Nov 13 2014 
      Irving Kahn Buys Stake in GlaxoSmithKline During Q3 2014 Nov 12 2014 
      Kahn Brothers' Third Quarter Numbers Nov 07 2014 
      Tweedy Browne Global Value Fund's Top Picks for Q3 Oct 21 2014 
      Diamond Hill Capital Comments on GlaxoSmithKline PLC Oct 17 2014 

      More From Other Websites
      Ex-B&Q Chief In Frame For Top Whitehall Role Dec 22 2014
      FDA approves BioCryst's intravenous flu drug Dec 22 2014
      Drugmaker Hikma on lookout for acquisitions Dec 21 2014
      GSK Ebola vaccine trial seen moving to wider phase in February Dec 19 2014
      Avon bribed Chinese officials with Gucci bags Dec 18 2014
      The year the sun set on the Bric economies Dec 18 2014
      The sun is setting on the emerging market miracle Dec 18 2014
      Five predictions for Britain's battered supermarket industry in 2015 Dec 18 2014
      BUZZ-Agenus Inc: Partner GSK's shingles vaccine meets goal Dec 18 2014
      GSK shareholders approve asset swap deal with Novartis Dec 18 2014
      GlaxoSmithKline shingles vaccine hits goal in major study Dec 18 2014
      Specialist City anti-corruption unit to be set up after scandals Dec 17 2014
      Global business leaders join fight against ebola at UN conference Dec 11 2014
      Merck suspends trial of Ebola vaccine Dec 11 2014
      McLaren speeds up GSK with racetrack expertise Dec 10 2014
      FTSE 100 movers: Ashtead boosted by first-half profits, gas companies still struggling Dec 10 2014
      Top Executives Quit Woodford Funds Venture Dec 09 2014
      Cubist move highlights antibiotics appeal Dec 08 2014
      Sukuk for vaccine fund ushers Islamic finance into ethical sphere Dec 07 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial